Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Literature DB >> 2155595

Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Y Yamada¹, N Yamamoto, K Maeno, Y Nishiyama.

Abstract

Camptothecin (CPT), a specific inhibitor of DNA topoisomerase I, effectively inhibited the replication of herpes simplex virus type 2 (HSV-2). CPT was found to reduce the level of immediate early viral mRNA in a dose-response manner. On the other hand, we could not find any evidence that a novel DNA topoisomerase I was induced in HSV-2-infected cells. Our observations suggest that host cell DNA topoisomerase I is involved in the replication of HSV-2.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1990 PMID： 2155595 DOI： 10.1007/BF01310708

Source DB: PubMed Journal: Arch Virol ISSN： 0304-8608 Impact factor: 2.574

15 in total

Review 1. Recent studies of DNA topoisomerases.

Authors: J C Wang
Journal: Biochim Biophys Acta Date: 1987-06-06

2. Aphidicolin inhibits eukaryotic DNA replication and repair --- implications for involvement of DNA polymerase alpha in both processes.

Authors: N A Berger; K K Kurohara; S J Petzold; G W Sikorski
Journal: Biochem Biophys Res Commun Date: 1979-07-12 Impact factor: 3.575

3. Studies on DNA topoisomerases I and II in herpes simplex virus type 2-infected cells.

Authors: A R Bapat; F S Han; Z C Liu; B S Zhou; Y C Cheng
Journal: J Gen Virol Date: 1987-08 Impact factor: 3.891

4. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme.

Authors: R Shaffer; P Traktman
Journal: J Biol Chem Date: 1987-07-05 Impact factor: 5.157

5. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

Authors: T Andoh; K Ishii; Y Suzuki; Y Ikegami; Y Kusunoki; Y Takemoto; K Okada
Journal: Proc Natl Acad Sci U S A Date: 1987-08 Impact factor: 11.205

6. Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication.

Authors: Y Nishiyama; H Fujioka; T Tsurumi; N Yamamoto; K Maeno; S Yoshida; K Shimokata
Journal: J Gen Virol Date: 1987-03 Impact factor: 3.891

7. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

Authors: N Yamamoto; M Fukushima; T Tsurumi; K Maeno; Y Nishiyama
Journal: Biochem Biophys Res Commun Date: 1987-08-14 Impact factor: 3.575

8. A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors: W R Bauer; E C Ressner; J Kates; J V Patzke
Journal: Proc Natl Acad Sci U S A Date: 1977-05 Impact factor: 11.205

9. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors: Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal: J Biol Chem Date: 1985-11-25 Impact factor: 5.157

10. Association of type I DNA topoisomerase with herpes simplex virus.

Authors: M T Muller; C S Bolles; D S Parris
Journal: J Gen Virol Date: 1985-07 Impact factor: 3.891

8 in total

1. DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.

Authors: Kei Takahashi; Peter Halfmann; Masaaki Oyama; Hiroko Kozuka-Hata; Takeshi Noda; Yoshihiro Kawaoka
Journal: J Virol Date: 2013-05-08 Impact factor: 5.103

2. Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.

Authors: J L Zhang; P L Sharma; C J Li; B J Dezube; A B Pardee; C S Crumpacker
Journal: Antimicrob Agents Chemother Date: 1997-05 Impact factor: 5.191

Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Review 1. Recent studies of DNA topoisomerases.

2. Aphidicolin inhibits eukaryotic DNA replication and repair --- implications for involvement of DNA polymerase alpha in both processes.

3. Studies on DNA topoisomerases I and II in herpes simplex virus type 2-infected cells.

4. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme.

5. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

6. Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication.

7. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

8. A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

9. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

10. Association of type I DNA topoisomerase with herpes simplex virus.

1. DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.

2. Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.

Review 3. Perspectives on biologically active camptothecin derivatives.

4. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

5. Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase.

6. Lack of in vitro antiviral activity of fluoroquinolones against herpes simplex virus type 2.

7. Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target.

Review 8. HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors.